Nicotinamide prevents the down-regulation of MEK/ERK/p90RSK signaling cascade in brain ischemic injury

Journal of Veterinary Medical Science

Volumn 74, Issue 1, 2012, Pages 35-41

  Sung, Jin Hee ^a   Kim, Myeong Ok ^a   Koh, Phil Ok ^a  

^a Gyeongsang National University   (South Korea)

Author keywords

Brain ischemia; MCAO; Nicotinamide

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE; NICOTINAMIDE; S6 KINASE; VITAMIN B COMPLEX;

ANIMAL; ARTICLE; BRAIN INFARCTION; BRAIN INJURY; BRAIN ISCHEMIA; DOWN REGULATION; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; MALE; METABOLISM; PATHOLOGY; RAT; SPRAGUE DAWLEY RAT;

ANIMALS; BRAIN INJURIES; BRAIN ISCHEMIA; CEREBRAL INFARCTION; DOWN-REGULATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION REGULATION, ENZYMOLOGIC; MALE; MAP KINASE KINASE KINASES; NIACINAMIDE; RATS; RATS, SPRAGUE-DAWLEY; RIBOSOMAL PROTEIN S6 KINASES, 90-KDA; VITAMIN B COMPLEX;

RATTUS;

EID: 84863083233     PISSN: 09167250     EISSN: 13477439     Source Type: Journal    
DOI: 10.1292/jvms.11-0149     Document Type: Article

References (28)

1. Allen, C.L. and Bayraktutan, U. 2009. Oxidative stress and its role in the pathogenesis of ischaemic stroke. Int. J. Stroke 4: 461-470.
2. Ayoub, I.A., Lee, E.J., Ogilvy, C.S., Beal, M.F. and Maynard, K.I. 1999. Nicotinamide reduces infarction up to two hours after the onset of permanent focal cerebral ischemia in Wistar rats. Neurosci. Lett. 259: 21-24.
3. Birkmayer, J.G. 1996. Coenzyme nicotinamide adenine dinu-cleotide: new therapeutic approach for improving dementia of the Alzheimer type. Ann. Clin. Lab. Sci. 26: 1-9.
4. Blomgren, K. and Hagberg, H. 2006. Free radicals, mitochondria, and hypoxia-ischemia in the developing brain. Free Radic. Biol. Med. 40: 388-397.
5. Bonni, A., Brunet, A., West, A.E., Datta, S.R., Takasu, M.A. and Greenberg, M.E. 1999. Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms. Science 286: 1358-1362.
6. Braidy, N., Guillemin, G. and Grant, R. 2008. Promotion of cellular NAD(+) anabolism: therapeutic potential for oxidative stress in ageing and Alzheimer's disease. Neurotox. Res. 13: 173-184.
7. Chong, Z.Z., Lin, S.H. and Maiese, K. 2004. The NAD+ precursor nicotinamide governs neuronal survival during oxida-tive stress through protein kinase B coupled to FOXO3a and mitochondrial membrane potential. J. Cereb. Blood Flow. Metab. 24: 728-743.
8. Chong, Z.Z., Lin, S.H., Li, F. and Maiese, K. 2005. The sirtuin inhibitor nicotinamide enhances neuronal cell survival during acute anoxic injury through AKT, BAD, PARP, and mitochon-drial associated anti-apoptotic pathways. Curr. Neurovasc.Res. 2: 271-285.
9. Crowley, C.L., Payne, C.M., Bernstein, H., Bernstein, C. and Roe, D. 2000. The NAD+ precursors, nicotinic acid and nicoti-namide protect cells against apoptosis induced by a multiple stress inducer, deoxycholate. Cell Death Differ. 7: 314-326.
10. Dalby, K.N., Morrice, N., Caudwell, F.B., Avruch, J. and Cohen, P. 1998. Identification of regulatory phosphorylation sites in mitogen-activated protein kinase (MAPK)-activated protein kinase-1a/p90rsk that are inducible by MAPK. J. Biol. Chem. 273: 1496-1505.
11. Frodin, M. and Gammeltoft, S. 1999. Role and regulation of 90 kDa ribosomal S6 kinase (RSK) in signal transduction. Mol. Cell. Endocrinol. 151: 65-77.
12. Hoane, M.R., Kaplan, S.A. and Ellis, A.L. 2006. The effects of nicotinamide on apoptosis and blood-brain barrier breakdown following traumatic brain injury. Brain Res. 1125: 185-193.
13. Kamat, J.P. and Devasagayam, T.P. 1999. Nicotinamide (vitamin B3) as an effective antioxidant against oxidative damage in rat brain mitochondria. Redox. Rep. 4: 179-184.
14. Klaidman, L.K., Mukherjee, S.K., Hutchin, T.P. and Adams, J.D. 1996. Nicotinamide as a precursor for NAD+ prevents apoptosis in the mouse brain induced by tertiary-butylhydro-peroxide. Neurosci. Lett. 206: 5-8.
15. Klaidman, L., Morales, M., Kem, S., Yang, J., Chang, M.L. and Adams, J.D. 2003. Nicotinamide offers multiple protective mechanisms in stroke as a precursor for NAD+, as a PARP inhibitor and by partial restoration of mitochondrial function. Pharmacology 69: 150-157.
16. Lin, S.H., Vincent, A., Shaw, T., Maynard, K.I. and Maiese, K. 2000. Prevention of nitric oxide-induced neuronal injury through the modulation of independent pathways of programmed cell death. J. Cereb. Blood Flow. Metab. 20: 1380-1391.
17. Longa, E.Z., Weinstein, P.R., Carlson, S. and Cummins, R. 1989. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 20: 84-91.
18. Marais, R., Wynne, J. and Treisman, R. 1993. The SRF accessory protein Elk-1 contains a growth factor-regulated transcrip-tional activation domain. Cell 73: 381-393.
19. Masters, S.C., Yang, H., Datta, S.R., Greenberg, M.E. and Fu, H. 2001. 14-3-3 inhibits Bad-induced cell death through interaction with serine-136. Mol. Pharmacol. 60: 1325-1331.
20. Mokudai, T., Ayoub, I.A., Sakakibara, Y., Lee, E.J., Ogilvy, C.S. and Maynard, K.I. 2000. Delayed treatment with nicotina-mide (Vitamin B(3)) improves neurological outcome and reduces infarct volume after transient focal cerebral ischemia in Wistar rats. Stroke 31: 1679-1685.
21. Mukherjee, S., Sonee, M. and Adams, J.D. 2005. A review of the regulatory role of nicotinamide on pro and anti-apoptotic proteins in neuronal cells. Lett. Drug. Design. Disc. 2: 551-557.
22. Pearson, G., Robinson, F., Gibson, T., Xu, B.E., Karandikar, M., Berman, K. and Cobb, M.H. 2001. Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr. Rev. 22: 153-183.
23. Sakakibara, Y., Mitha, A.P., Ogilvy, C.S. and Maynard, K.I. 2000. Post-treatment with nicotinamide (vitamin B(3)) reduces the infarct volume following permanent focal cerebral ischemia in female Sprague-Dawley and Wistar rats. Neurosci. Lett. 281: 111-114.
24. Shimamura, A., Ballif, B.A., Richards, S.A. and Blenis, J. 2000. Rsk1 mediates a MEK-MAP kinase cell survival signal. Curr. Biol. 10: 127-135.
25. Sung, J.H., Kim, M.O. and Koh, P.O. 2011. Proteomic identification of proteins differentially expressed by nicotinamide in focal cerebral ischemic injury. Neuroscience 174: 171-177.
26. Yang, E., Zha, J., Jockel, J., Boise, L.H., Thompson, C.B. and Korsmeyer, S.J. 1995. Bad, a heterodimeric partner for Bcl-XL and Bcl-2, displaces Bax and promotes cell death. Cell 80: 285-291.
27. Yang, J., Klaidman, L.K., Nalbandian, A., Oliver, J., Chang, M.L., Chan, P.H. and Adams, J.D. 2002. The effects of nicoti-namide on energy metabolism following transient focal cerebral ischemia in Wistar rats. Neurosci. Lett. 333: 91-94.
28. Yang, J., Klaidman, L.K., Chang, M.L., Kem, S., Sugawara, T., Chan, P. and Adams, J.D. 2002. Nicotinamide therapy protects against both necrosis and apoptosis in a stroke model. Pharmacol. Biochem. Behav. 73: 901-910.